BSE Code: | NSE Code: | ISIN: | Sector:

NSE
540.40
Change Change %
4.65 0.87%

Updated:23 Oct, 2017, 15:59 PM IST

BSE
538.05
Change Change %
2.45 0.46%

Updated:23 Oct, 2017, 15:54 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Nomura
N/A
14-08-2017 Hold 452.00 600.00
N/A
Open Long (1Y)
14-08-2018

Nomura maintains neutral on Sun Pharmaceuticals

Sun Pharma's earnings were materially lower than our estimates with sales and EBITDA missing our estimates by 8% and 27%, respectively. The slowdown in India (-5% y-y) is largely along expected lines. However, US revenues came in lower on higher pricing pressure. Management guided for single digit revenue decline in FY18F and EBITDA margin expanding to just 20-22% by 2HFY18F. This indicates continued pressure in the business in the near term.

Market Data provided by © Accord Fintech. © Copyright NDTV Convergence Limited 2017. All rights reserved.